Risks of adverse outcomes and neonatal morbidity in pregnant women with SARS-CoV-2 depending on the trimester of infection

Introduction. COVID-19 in pregnant women adversely affects the course of the disease, pregnancy outcomes, and morbidity in newborns. However, studies on the impact of the gestational age at which SARS-CoV-2 infection occurs on the risk of neonatal morbidity are lacking.

Aim. To assess the risks of adverse pregnancy outcomes and neonatal morbidity in newborns depending on the gestational age at which women were infected with SARS-CoV-2.

Materials and methods. The study included 215 women infected with SARS-CoV-2 in the first, second, and third trimesters of pregnancy and 50 uninfected pregnant women. Newborns formed corresponding groups. Data for analysis (general clinical, anamnestic, childbirth outcomes, and newborn condition) were obtained from the records of pregnant, laboring, and postpartum women.

Results. In 4.7% of women infected in the first trimester, pregnancy was accompanied by spontaneous miscarriage and in 1.9% by ectopic pregnancy development. In 1.9% of women infected in the second trimester, antenatal fetal demise in a full-term pregnancy was detected. Patients infected with SARS-CoV-2 more often underwent cesarean section (31.7%). The median weight and height of newborns from mothers infected with SARS-CoV-2 were lower than in the control group. The Apgar score at the first minute showed no differences, but at the fifth minute, it was lower than in the control group. Newborns from mothers infected with SARS-CoV-2 were more frequently diagnosed with cerebral ischemia (26.3%), motor disorder syndrome (20.7%), and persistent fetal circulation (27.8%). Only in newborns from mothers with SARS-CoV-2 were hypertensive syndrome (13.1%), posthypoxic cardiomyopathy (13.1%), and intraventricular hemorrhages (10.1%) detected. The Apgar score at the first minute in newborns from mothers infected with SARS-CoV-2 in the third trimester of pregnancy was higher compared to infections in the second trimester. Neonatal morbidity in this cohort of newborns was characterized by a high frequency of cerebral ischemia, motor disorder syndrome, hypertensive syndrome, and persistent fetal circulation. Infection in the third trimester increased the risk of neonatal morbidity: cerebral ischemia by 5.6 times, motor disorder syndrome by 13.78 times, hypertensive syndrome by 8.61 times, and persistent fetal circulation by 2.76 times.

Conclusion. COVID-19 during pregnancy increases the risks of adverse outcomes and the development of neonatal pathology in newborns. The frequency of their development is associated with the gestational age at which women were infected. Infection of women with SARS-CoV-2 in the first and second trimesters of pregnancy increases the risk of spontaneous miscarriage and antenatal fetal death, in the third trimester – the development of intraventricular hemorrhages and posthypoxic cardiomyopathy in newborns.

1. Rasmussen S.A., Jamieson D.J. COVID-19 and pregnancy. Infect. Dis. Clin. North. Am. 2022; 36(2):423–433. https://doi.org/10.1016/j.idc.2022.01.002

2. Zhukovec I.V., Andrievskaja I.A., Krivoshhekova N.A., Smirnova N.A., Petrova K.K., Harchenko M.V., Nikachalo D.A. [Early effects of the COVID-19 pandemic: pregnancy complications, newborn health, and expected reproductive losses]. Bjulleten' fiziologii i patologii dyhanija = Bulletin of physiology and pathology of respiration 2022; 84:77–85 (in Russian). https://doi.org/10.36604/1998-5029-2022-84-77-85

3. Schwartz D.A. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch. Pathol. Lab. Med. 2020; 144(7):799–805. https://doi.org/10.5858/arpa.2020-0901-SA

4. Priputnevich T.V., Gordeev A.B., Ljubasovskaja L.A., Shabanova N.E. [Novel SARS-COV-2 coronavirus and pregnancy: a review of the literature]. Akusherstvo i ginekologiya = Obstetrics and Gynecology 2020; 5:6–12 (in Russian). https://dx.doi.org/10.18565/aig.2020.5.6-12

5. Bezhenar' V.F., Romanova M.L., Nesterov I.M., Dobrovol'skaja I.A. [Analysis of the course and outcomes of pregnancy in women with different degrees of severity of new COVID-19 coronavirus infection in St. Petersburg: lessons from the pandemic]. Akusherstvo, Ginekologiya i Reproduktsiya = Obstetrics, Gynecology and Reproduction 2022; 16(4):365–380 (in Russian). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.314

6. Wei S.Q., Bilodeau-Bertrand M., Liu S., Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021; 193(16):540-548. https://doi.org/10.1503/cmaj.202604

7. Smith E.R., Oakley E., Grandner G.W., Ferguson K., Farooq F., Afshar Y., Ahlberg M., Ahmadzia H., Akelo V., Aldrovandi G., Tippett Barr B.A., Bevilacqua E., Brandt J.S., Broutet N., Fernández Buhigas I., Carrillo J., Clifton R., Conry J., Cosmi E., Crispi F., Crovetto F., Delgado-López C., Divakar H., Driscoll A.J., Favre G., Flaherman V.J., Gale C., Gil M.M., Gottlieb S.L., Gratacós E., Hernandez O., Jones S., Kalafat E., Khagayi S., Knight M., Kotloff K., Lanzone A., Le Doare K., Lees C., Litman E., Lokken E.M., Laurita Longo V., Madhi S.A., Magee L.A., Martinez-Portilla R.J., McClure E.M., Metz T.D., Miller E.S., Money D., Moungmaithong S., Mullins E., Nachega J.B., Nunes M.C., Onyango D., Panchaud A., Poon L.C., Raiten D., Regan L., Rukundo G., Sahota D., Sakowicz A., Sanin-Blair J., Söderling J., Stephansson O., Temmerman M., Thorson A., Tolosa J.E., Townson J., Valencia-Prado M., Visentin S., von Dadelszen P., Adams Waldorf K., Whitehead C., Yassa M., Tielsch J.M., Perinatal COVID PMA Study Collaborators. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data metaanalysis. BMJ Glob. Health 2023; 8(1):e009495. https://doi.org/10.1136/bmjgh-2022-009495

8. Di Toro F., Gjoka M., Di Lorenzo G., De Santo D., De Seta F., Maso G., Risso F.M., Romano F., Wiesenfeld U., Levi-D'Ancona R., Ronfani L., Ricci G. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin. Microbiol. Infect. 2021; 27(1):36–46. https://doi.org/10.1016/j.cmi.2020.10.007

9. Chmielewska B., Barratt I., Townsend R., Kalafat E., van der Meulen J., Gurol-Urganci I., O'Brien P., Morris E., Draycott T., Thangaratinam S., Le Doare K., Ladhani S., von Dadelszen P., Magee L., Khalil A. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob. Health 2021; 9(6):759– 772. https://doi.org/10.1016/S2214-109X(21)00079-6

10. Junior L.C.M., Pinto C.N., Gerencer C.S., Pro E.C.G., de Carvalho H.B. Association of maternal, fetal and labor variables with a low Apgar score in the fifth minute in term pregnancy: a case-control study. Arch. Gynecol. Obstet. 2023; 308(5):1473–1483. https://doi.org/10.1007/s00404-022-06832-6